MBS8400302 | Anti-VEGF-A (Brolucizumab); Humanized Antibody

(No reviews yet) Write a Review
Usually Shipped in 5 Working Days
AUD671.00 - AUD2,840.00
Frequently bought together:


Anti-VEGF-A (Brolucizumab); Humanized Antibody | MBS8400302 | Mybiosource

Product Short Name: [VEGF-A]

Product Name Synonyme: [ESBA-1008; ESBA1008; RTH-258; RTH258; VPF; VEGF; MVCD1; VEGFA]

Other Names: N/A

Product Gene Name: [VEGF-A]

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: scFv-kappa-heavy

Clone: N/A

Host: Human

Reactivity: Human

Specificity: The biosimilar is a humanized scFv antibody fragment that targets VEGF-A and prevents neovascularization and proliferation of endothelial cells. The original monoclonal antibody is approved to treat wet age-related macular degeneration

Purity: Protein A purified

Form: Colorless liquid. In PBS; pH7.5

Concentration: 1mg/ml

Storage Stability: Store at -80 degree C. The antibody solution should be gently mixed before use.
Shipping: Gel Pack
Shelf Life: Est.~12 months
Country of Origin: USA

Tested Application: N/A

View AllClose